Bieroń K - Search Results

1

Effect of heparin and prostacyclin/heparin infusion on platelet aggregation in hemodialyzed patients.

Kuźniewski M, Sułowicz W, Hanicki Z, Kus J, Nowogrodzka-Zagórska M, Kostka-Trabka E, Bieroń K, Debińska-Kieć A. Kuźniewski M, et al. Among authors: bieron k. Nephron. 1990;56(2):174-8. doi: 10.1159/000186128. Nephron. 1990. PMID: 2243573

2

Interaction between prostacyclin and molsidomine in blood cells and plasma.

Gryglewski RJ, Bieroń K, Dembińska-Kieć A, Kostka-Trabka E, Zembowicz A. Gryglewski RJ, et al. Among authors: bieron k. Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:655-8. Adv Prostaglandin Thromboxane Leukot Res. 1991. PMID: 1825393 No abstract available.

3

Prostacyclin and molsidomine synergise in their fibrinolytic and anti-platelet actions in patients with peripheral arterial disease.

Bieroń K, Grodzińska L, Kostka-Trabka E, Gryglewski RJ. Bieroń K, et al. Wien Klin Wochenschr. 1993;105(1):7-11. Wien Klin Wochenschr. 1993. PMID: 8438599 Clinical Trial.

4

Thrombolytic and antiplatelet action of xanthinol nicotinate (Sadamin): possible mechanisms.

Bieroń K, Swies J, Kostka-Trabka E, Gryglewski RJ. Bieroń K, et al. J Physiol Pharmacol. 1998 Jun;49(2):241-9. J Physiol Pharmacol. 1998. PMID: 9670107

5

Increased platelet activity after termination of prostacyclin infusion into man.

Dembinska-Kiec A, Zmuda A, Grodzinska L, Bieron K, Basista M, Kedzior A, Kostka-Trabka E, Telesz E, Zelazny T. Dembinska-Kiec A, et al. Among authors: bieron k. Prostaglandins. 1981 May;21(5):827-32. doi: 10.1016/0090-6980(81)90239-2. Prostaglandins. 1981. PMID: 6803307

6

Treatment of ischaemic stroke with prostacyclin.

Gryglewski RJ, Nowak S, Kostka-Trabka E, Kusmiderski J, Dembinska-Kiec A, Bieron K, Basista M, Blaszczyk B. Gryglewski RJ, et al. Among authors: bieron k. Stroke. 1983 Mar-Apr;14(2):197-202. doi: 10.1161/01.str.14.2.197. Stroke. 1983. PMID: 6340253

7

Lack of beneficial effects of L-arginine infusion in primary pulmonary hypertension.

Surdacki A, Zmudka K, Bieroń K, Kostka-Trabka E, Dubiel JS, Gryglewski RJ. Surdacki A, et al. Among authors: bieron k. Wien Klin Wochenschr. 1994;106(16):521-6. Wien Klin Wochenschr. 1994. PMID: 7975663 Clinical Trial.

8

Thrombolytic action of ticlopidine: possible mechanisms.

Gryglewski RJ, Korbut R, Swies J, Kostka Trabka E, Bieroń K, Robak J. Gryglewski RJ, et al. Among authors: bieron k. Eur J Pharmacol. 1996 Jul 11;308(1):61-7. doi: 10.1016/0014-2999(96)00256-7. Eur J Pharmacol. 1996. PMID: 8836633

9

Treatment of peripheral vascular disease with misoprostol (Cytotec): a pilot study.

Goszcz A, Grodzinska L, Kostka-Trabka E, Bieron K, Slawinski M, Jachym R, Ochmanski W. Goszcz A, et al. Among authors: bieron k. Methods Find Exp Clin Pharmacol. 1998 Jun;20(5):439-45. doi: 10.1358/mf.1998.20.5.485706. Methods Find Exp Clin Pharmacol. 1998. PMID: 9701783 Free article.

10

Effect of prostacyclin (PGI2) on platelets and fibrinolytic activity in patients with arteriosclerosis obliterans.

Dembińska-Kieć A, Kostka-Trabka E, Zumda A, Byrska-Danek A, Bierón K, Grodzińska L, Kedzior A, Zelazny T. Dembińska-Kieć A, et al. Among authors: bieron k. Pharmacol Res Commun. 1982 Jun;14(6):485-98. doi: 10.1016/s0031-6989(82)80039-8. Pharmacol Res Commun. 1982. PMID: 6750655 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters